Search

Author/Creator McLaughlin, Kirsty

1. A revised model of TRAIL‐R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis. (3rd February 2020)

Authors:
Humphreys, Luke M; Fox, Jennifer P; Higgins, Catherine A; Majkut, Joanna; Sessler, Tamas; McLaughlin, Kirsty; McCann, Christopher; Roberts, Jamie Z; Crawford, Nyree T; McDade, Simon S; Scott, Christopher J; Harrison, Timothy; Longley, Daniel B
Journal:
EMBO reports
Issue:
Volume 21:Number 3(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prognostic and therapeutic relevance of c‐FLIP in acute myeloid leukaemia. (20th November 2012)

Authors:
McLornan, Donal; Hay, Jodie; McLaughlin, Kirsty; Holohan, Caitriona; Burnett, Alan K.; Hills, Robert K.; Johnston, Patrick G.; Mills, Ken I.; McMullin, Mary Frances; Longley, Daniel B.
Journal:
British journal of haematology
Issue:
Volume 160:Number 2(2013:Jan.)
Page Start:
188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. Issue 42 (18th October 2019)

Authors:
McDaid, William J.; Greene, Michelle K.; Johnston, Michael C.; Pollheimer, Ellen; Smyth, Peter; McLaughlin, Kirsty; Van Schaeybroeck, Sandra; Straubinger, Robert M.; Longley, Daniel B.; Scott, Christopher J.
Journal:
Nanoscale
Issue:
Volume 11:Issue 42(2019)
Page Start:
20261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗